Skip to main content
Livermore
Livermore
ZHEN

CIBC Private Wealth Group, LLC

SEC CIK
0001298088
Latest filing
Feb 12, 2026

AVDL holding history

Avadel Pharmaceuticals PLC in every 13F filed by CIBC Private Wealth Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVDL overviewAll 13F holders of AVDLFull Q4 2025 holdings

Shares (Q4 2025)
8,000
Value
$172.4K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of AVDL by CIBC Private Wealth Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20258,000$172.4K<0.1%00.0%UnchangedHolders
Q3 20258,000$122.2K<0.1%+8,000NewHolders
Q2 20250$00.0%−78,253−100.0%Sold outHolders
Q1 202578,253$515.7K<0.1%00.0%UnchangedHolders
Q4 202478,253$836.5K<0.1%00.0%UnchangedHolders
Q3 202478,253$1.03M<0.1%+78,253NewHolders
Q2 20240$00.0%−58,934−100.0%Sold outHolders
Q1 202458,934$981.8K<0.1%−4,695−7.4%ReducedHolders
Q4 202363,629$898.4K<0.1%−29,799−31.9%ReducedHolders
Q3 202393,428$962.3K<0.1%−82−0.1%ReducedHolders
Q2 202393,510$1.54M<0.1%−49,575−34.6%ReducedHolders
Q1 2023143,085$1.31M<0.1%+4,080+2.9%AddedHolders
Q4 2022139,005$995.3K<0.1%−20,000−12.6%ReducedHolders
Q3 2022159,005$797.0K<0.1%−6,000−3.6%ReducedHolders
Q2 2022165,005$403.0K<0.1%+58,934+55.6%AddedHolders
Q1 2022106,071$724.0K<0.1%−59,284−35.9%ReducedHolders
Q4 2021165,355$1.34M<0.1%00.0%UnchangedHolders
Q3 2021165,355$1.62M<0.1%00.0%UnchangedHolders
Q2 2021165,355$1.11M<0.1%00.0%UnchangedHolders
Q1 2021165,355$1.50M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.